We are live on ! Find out more
MURA

Mural Oncology
MURA

Delisted

MURA was delisted on the 4th of December, 2025.

Back to rankings

76 hedge funds and large institutions have $30.5M invested in Mural Oncology in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 23 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

3% more funds holding

Funds holding: 74 → 76 (+2)

2% more capital invested

Capital invested by funds: $29.8M → $30.5M (+$650K)

0.45% less ownership

Funds ownership: 55.88% → 55.44% (-0.45%)

26% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 23

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $111K

Holders
76
Holders Change
+2
Holders Change %
+2.7%
% of All Funds
1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
17
Reduced
23
Closed
9
Calls
–
Puts
$111K
Net Calls
-$111K
Net Calls Change
-$124K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$311K
2
Goldman Sachs
Goldman Sachs
New York
+$231K
3
Morgan Stanley
Morgan Stanley
New York
+$180K
4
VF
Virtu Financial
New York
+$141K
5
Renaissance Technologies
Renaissance Technologies
New York
+$125K

Top Sellers

Rank Fund Capital Flow
1
AFA
Alta Fundamental Advisers
New York
-$2.25M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$1.05M
3
CC
Centiva Capital
New York
-$638K
4
Verition Fund Management
Verition Fund Management
Connecticut
-$469K
5
PM
Prosight Management
Texas
-$366K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
51
Tower Research Capital (TRC)
New York
$1.69K +$1.16K +330 +169%
AAM
52
Advisors Asset Management
Colorado
$1.64K – – –
Bank of America
53
Bank of America
North Carolina
$1.6K -$2.33K -661 -57%
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
$1K +$881 +250 +158%
JP Morgan Chase
55
JP Morgan Chase
New York
$782 -$11 -3 -1%
QC
56
Quent Capital
New York
$216 +$42 +12 +22%
PNC Financial Services Group
57
PNC Financial Services Group
Pennsylvania
$200 – – –
Barclays
58
Barclays
United Kingdom
$177 -$155 -44 -44%
WT
59
Whittier Trust
California
$132 – – –
CSS
60
Cubist Systematic Strategies
Connecticut
$129 -$59.2K -16,804 -100%
National Bank of Canada
61
National Bank of Canada
Quebec, Canada
$71 – – –
DCM
62
Davis Capital Management
Florida
$64 – – –
NA
63
NewEdge Advisors
Louisiana
$48 +$35 +10 +200%
KOCAA
64
Knights of Columbus Asset Advisors
Connecticut
$32 – – –
Northwestern Mutual Wealth Management
65
Northwestern Mutual Wealth Management
Wisconsin
$32 – – –
MCM
66
MAI Capital Management
Ohio
$23 +$25 +7 New
Citigroup
67
Citigroup
New York
$16 – – –
BIA
68
Bell Investment Advisors
California
$13 – – –
CWM
69
Cranbrook Wealth Management
Michigan
$13 – – –
FFA
70
Farther Finance Advisors
California
$3 – – –
LC
71
Lindbrook Capital
California
$3 – – –
TCM
72
TD Capital Management
Tennessee
$3 – – –
VCM
73
Versant Capital Management
Arizona
$3 – – –
AFA
74
Alta Fundamental Advisers
New York
– -$2.25M -720,143 Closed
CC
75
Centiva Capital
New York
– -$638K -203,706 Closed
1 2
3
4

MURA Hedge Fund Activity: Q4 2024 in Review

76 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q4 2024, worth a combined $30.5M — up 2.2% from $29.8M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new MURA positions and 9 closed out — a net gain of 2 holders — while 17 added to existing stakes and 23 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $311K. The largest seller was Alta Fundamental Advisers, exiting entirely with an estimated $2.25M sold.

  • 76 institutional investors held Mural Oncology (MURA) as of Q4 2024, up from 74 in Q3 2024.
  • Funds reported $30.5M of Mural Oncology stock for Q4 2024, up 2.2% quarter-over-quarter.
  • 11 funds opened new Mural Oncology positions in Q4 2024 and 9 closed out, a net change of +2 holders.
  • The largest Mural Oncology buyer in Q4 2024 was Citadel Advisors, an estimated $311K added.
  • The largest Mural Oncology seller in Q4 2024 was Alta Fundamental Advisers, an estimated $2.25M sold.

Based on aggregated 13F filings for Q4 2024.